Because rare proteasome loss-of-function mutations typically cause type I interferonopathies (59, 60, 74), we next aimed to determine whether protein homeostasis disruption triggered by BTZ, ONX0914, RA190 or PR619 was associated with the acquisition of a type I IFN gene signature in MM. This evidence concerns the gene CASC3 and Miyoshi myopathy.